 Paul MacLean
Concepts (577)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 56 | 2025 | 2962 | 5.160 |
Why?
| | Weight Gain | 26 | 2023 | 532 | 4.590 |
Why?
| | Energy Metabolism | 32 | 2024 | 922 | 4.460 |
Why?
| | Weight Loss | 26 | 2025 | 783 | 4.160 |
Why?
| | Physical Conditioning, Animal | 10 | 2025 | 254 | 2.390 |
Why?
| | Rats, Wistar | 19 | 2024 | 453 | 2.240 |
Why?
| | Energy Intake | 18 | 2025 | 506 | 2.150 |
Why?
| | Dietary Fats | 14 | 2019 | 299 | 1.850 |
Why?
| | Caloric Restriction | 9 | 2025 | 124 | 1.760 |
Why?
| | Ovariectomy | 11 | 2025 | 156 | 1.740 |
Why?
| | Body Weight | 16 | 2024 | 992 | 1.500 |
Why?
| | Lactation | 8 | 2020 | 174 | 1.480 |
Why?
| | Adipose Tissue | 15 | 2022 | 643 | 1.420 |
Why?
| | Appetite | 3 | 2025 | 71 | 1.360 |
Why?
| | Diet, High-Fat | 15 | 2023 | 247 | 1.350 |
Why?
| | Milk, Human | 6 | 2022 | 153 | 1.310 |
Why?
| | Body Composition | 12 | 2024 | 694 | 1.220 |
Why?
| | Rats | 34 | 2024 | 5594 | 1.150 |
Why?
| | Adipocytes | 7 | 2025 | 227 | 1.120 |
Why?
| | Muscle, Skeletal | 20 | 2022 | 1729 | 1.120 |
Why?
| | Ovary | 4 | 2024 | 223 | 1.040 |
Why?
| | Fatty Acids, Omega-6 | 2 | 2017 | 48 | 1.040 |
Why?
| | Diet, Fat-Restricted | 6 | 2015 | 78 | 1.040 |
Why?
| | Animals | 77 | 2025 | 37217 | 1.000 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2017 | 139 | 0.960 |
Why?
| | Lipid Metabolism | 9 | 2017 | 522 | 0.960 |
Why?
| | Motor Activity | 3 | 2019 | 710 | 0.950 |
Why?
| | Appetite Regulation | 2 | 2017 | 32 | 0.870 |
Why?
| | Adaptation, Physiological | 7 | 2018 | 548 | 0.840 |
Why?
| | Liver | 11 | 2024 | 1805 | 0.810 |
Why?
| | Biomedical Research | 3 | 2023 | 694 | 0.800 |
Why?
| | Cholesterol | 5 | 2019 | 403 | 0.780 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 243 | 0.770 |
Why?
| | Fasting | 7 | 2025 | 283 | 0.770 |
Why?
| | Leptin | 8 | 2025 | 242 | 0.760 |
Why?
| | Vasopressins | 3 | 2021 | 60 | 0.760 |
Why?
| | Lipoprotein Lipase | 3 | 2021 | 56 | 0.760 |
Why?
| | Overweight | 5 | 2025 | 571 | 0.760 |
Why?
| | Body Weight Maintenance | 2 | 2019 | 16 | 0.750 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2023 | 325 | 0.750 |
Why?
| | Awards and Prizes | 1 | 2023 | 72 | 0.750 |
Why?
| | Estrogens | 3 | 2018 | 365 | 0.750 |
Why?
| | Breast Feeding | 5 | 2022 | 422 | 0.740 |
Why?
| | Eating | 5 | 2022 | 392 | 0.740 |
Why?
| | Lipogenesis | 3 | 2019 | 61 | 0.740 |
Why?
| | Mammary Neoplasms, Experimental | 3 | 2021 | 68 | 0.720 |
Why?
| | Mammary Glands, Animal | 5 | 2019 | 130 | 0.710 |
Why?
| | Glycoproteins | 5 | 2005 | 354 | 0.690 |
Why?
| | Receptor, Insulin | 3 | 2015 | 100 | 0.680 |
Why?
| | Insulin | 19 | 2022 | 2448 | 0.670 |
Why?
| | Exercise | 11 | 2025 | 2072 | 0.660 |
Why?
| | Estradiol | 1 | 2024 | 525 | 0.660 |
Why?
| | Milk | 5 | 2019 | 123 | 0.630 |
Why?
| | Oxygen Consumption | 5 | 2019 | 710 | 0.630 |
Why?
| | Thermogenesis | 2 | 2019 | 44 | 0.630 |
Why?
| | Physical Exertion | 3 | 2011 | 209 | 0.620 |
Why?
| | Female | 64 | 2025 | 73763 | 0.620 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2021 | 216 | 0.620 |
Why?
| | Cold Temperature | 2 | 2019 | 188 | 0.610 |
Why?
| | Carrier Proteins | 6 | 2005 | 737 | 0.610 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2018 | 611 | 0.590 |
Why?
| | Sex Characteristics | 3 | 2021 | 770 | 0.570 |
Why?
| | Mitochondria, Muscle | 1 | 2019 | 116 | 0.570 |
Why?
| | Menopause | 2 | 2019 | 316 | 0.570 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 53 | 0.560 |
Why?
| | Breast Neoplasms | 6 | 2022 | 2212 | 0.560 |
Why?
| | Diet | 10 | 2023 | 1269 | 0.530 |
Why?
| | Adipogenesis | 1 | 2017 | 57 | 0.530 |
Why?
| | Cortical Bone | 1 | 2017 | 19 | 0.530 |
Why?
| | Insulin Resistance | 9 | 2025 | 1222 | 0.520 |
Why?
| | Organic Cation Transport Proteins | 1 | 2017 | 25 | 0.520 |
Why?
| | Adiposity | 5 | 2016 | 519 | 0.520 |
Why?
| | Mice | 34 | 2025 | 17814 | 0.510 |
Why?
| | Diet, Reducing | 4 | 2021 | 91 | 0.510 |
Why?
| | Ibuprofen | 1 | 2017 | 82 | 0.510 |
Why?
| | Metformin | 2 | 2018 | 331 | 0.500 |
Why?
| | Placenta | 1 | 2023 | 753 | 0.500 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 98 | 0.490 |
Why?
| | Supraoptic Nucleus | 1 | 2015 | 4 | 0.490 |
Why?
| | Osteogenesis | 2 | 2017 | 197 | 0.480 |
Why?
| | Bone Density | 1 | 2019 | 489 | 0.470 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 409 | 0.470 |
Why?
| | Fructose | 5 | 2021 | 113 | 0.470 |
Why?
| | Gene Expression Regulation | 9 | 2021 | 2590 | 0.460 |
Why?
| | Oxytocin | 1 | 2015 | 52 | 0.460 |
Why?
| | Intra-Abdominal Fat | 2 | 2022 | 90 | 0.450 |
Why?
| | Therapies, Investigational | 1 | 2014 | 18 | 0.440 |
Why?
| | Mothers | 4 | 2018 | 764 | 0.440 |
Why?
| | Male | 58 | 2025 | 68260 | 0.430 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 347 | 0.430 |
Why?
| | Weight Reduction Programs | 3 | 2025 | 117 | 0.420 |
Why?
| | Fatty Acids | 8 | 2022 | 444 | 0.420 |
Why?
| | Transcription Factors | 12 | 2019 | 1697 | 0.400 |
Why?
| | Fructokinases | 5 | 2021 | 32 | 0.400 |
Why?
| | Basal Metabolism | 3 | 2021 | 62 | 0.400 |
Why?
| | Disease Models, Animal | 11 | 2021 | 4315 | 0.400 |
Why?
| | Monosaccharide Transport Proteins | 3 | 2002 | 51 | 0.400 |
Why?
| | Fatty Liver | 5 | 2018 | 230 | 0.390 |
Why?
| | Humans | 68 | 2025 | 138651 | 0.380 |
Why?
| | Overnutrition | 1 | 2012 | 30 | 0.380 |
Why?
| | Blood Glucose | 10 | 2019 | 2239 | 0.370 |
Why?
| | Anorexia Nervosa | 1 | 2013 | 90 | 0.360 |
Why?
| | Feeding Behavior | 5 | 2025 | 674 | 0.360 |
Why?
| | Pregnancy | 9 | 2023 | 6829 | 0.360 |
Why?
| | Recurrence | 4 | 2019 | 1084 | 0.360 |
Why?
| | Diabetes Mellitus | 6 | 2018 | 1068 | 0.350 |
Why?
| | Estrous Cycle | 1 | 2010 | 20 | 0.340 |
Why?
| | Receptors, Progesterone | 1 | 2012 | 337 | 0.330 |
Why?
| | Body Mass Index | 11 | 2025 | 2349 | 0.330 |
Why?
| | Lipoproteins | 3 | 2000 | 160 | 0.330 |
Why?
| | Homeostasis | 7 | 2015 | 614 | 0.330 |
Why?
| | Acetyl-CoA Carboxylase | 4 | 2014 | 32 | 0.320 |
Why?
| | RNA, Messenger | 10 | 2019 | 2815 | 0.320 |
Why?
| | Estrogen Receptor alpha | 2 | 2018 | 143 | 0.320 |
Why?
| | Vitamin D | 1 | 2013 | 393 | 0.310 |
Why?
| | Glucose | 10 | 2023 | 1032 | 0.310 |
Why?
| | Calorimetry, Indirect | 5 | 2021 | 84 | 0.300 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2023 | 22 | 0.300 |
Why?
| | National Institutes of Health (U.S.) | 2 | 2023 | 131 | 0.300 |
Why?
| | Huntington Disease | 2 | 2021 | 63 | 0.290 |
Why?
| | Dietary Carbohydrates | 5 | 2019 | 153 | 0.290 |
Why?
| | Behavior Therapy | 2 | 2021 | 273 | 0.290 |
Why?
| | Gastrointestinal Microbiome | 3 | 2023 | 696 | 0.290 |
Why?
| | Time Factors | 10 | 2019 | 6851 | 0.280 |
Why?
| | Promoter Regions, Genetic | 5 | 2017 | 1233 | 0.270 |
Why?
| | Peripheral Blood Stem Cell Transplantation | 1 | 2007 | 34 | 0.270 |
Why?
| | Mice, Inbred C57BL | 16 | 2025 | 5798 | 0.270 |
Why?
| | Adult | 31 | 2025 | 38201 | 0.260 |
Why?
| | Triglycerides | 8 | 2019 | 513 | 0.260 |
Why?
| | Adiponectin | 5 | 2025 | 240 | 0.250 |
Why?
| | Mammary Glands, Human | 2 | 2020 | 65 | 0.250 |
Why?
| | Neurons | 1 | 2015 | 1601 | 0.250 |
Why?
| | Leukocytes, Mononuclear | 2 | 2021 | 571 | 0.250 |
Why?
| | Antineoplastic Agents | 2 | 2017 | 2152 | 0.250 |
Why?
| | Mice, Knockout | 12 | 2021 | 3028 | 0.250 |
Why?
| | Transplantation, Autologous | 1 | 2007 | 275 | 0.250 |
Why?
| | Dehydration | 2 | 2016 | 54 | 0.240 |
Why?
| | Lymphoma | 1 | 2007 | 227 | 0.240 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2023 | 2490 | 0.240 |
Why?
| | Adenocarcinoma | 1 | 2012 | 885 | 0.240 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 177 | 0.240 |
Why?
| | Feces | 4 | 2023 | 486 | 0.240 |
Why?
| | Epithelium | 2 | 2019 | 316 | 0.230 |
Why?
| | Signal Transduction | 6 | 2022 | 5086 | 0.230 |
Why?
| | Muscle Proteins | 4 | 2012 | 239 | 0.230 |
Why?
| | Metabolic Syndrome | 3 | 2021 | 346 | 0.230 |
Why?
| | Leukemia | 1 | 2007 | 239 | 0.230 |
Why?
| | Sheep | 3 | 2023 | 864 | 0.230 |
Why?
| | Photoperiod | 2 | 2019 | 53 | 0.230 |
Why?
| | Transcriptome | 3 | 2024 | 967 | 0.220 |
Why?
| | Hematopoietic Stem Cells | 2 | 2025 | 410 | 0.220 |
Why?
| | DNA-Binding Proteins | 7 | 2019 | 1471 | 0.210 |
Why?
| | Multiple Myeloma | 1 | 2007 | 272 | 0.210 |
Why?
| | Adipose Tissue, White | 1 | 2024 | 43 | 0.210 |
Why?
| | Physical Fitness | 2 | 2016 | 206 | 0.210 |
Why?
| | Animals, Newborn | 3 | 2017 | 859 | 0.210 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2019 | 274 | 0.210 |
Why?
| | Cholesterol Ester Transfer Proteins | 5 | 2005 | 18 | 0.200 |
Why?
| | Resistance Training | 3 | 2017 | 166 | 0.200 |
Why?
| | Arteriosclerosis | 1 | 2003 | 83 | 0.200 |
Why?
| | Financing, Organized | 1 | 2023 | 38 | 0.200 |
Why?
| | Fetal Development | 2 | 2023 | 297 | 0.200 |
Why?
| | Transcriptional Activation | 2 | 2002 | 376 | 0.200 |
Why?
| | Animal Feed | 3 | 2019 | 54 | 0.200 |
Why?
| | Hospitalization | 1 | 2013 | 2235 | 0.200 |
Why?
| | Sequence Analysis, RNA | 3 | 2021 | 448 | 0.200 |
Why?
| | Cell Proliferation | 3 | 2017 | 2480 | 0.200 |
Why?
| | Ghrelin | 3 | 2025 | 36 | 0.200 |
Why?
| | Parturition | 1 | 2023 | 67 | 0.190 |
Why?
| | Oxidation-Reduction | 6 | 2019 | 1076 | 0.190 |
Why?
| | Tamoxifen | 3 | 2021 | 202 | 0.190 |
Why?
| | Exercise Tolerance | 3 | 2016 | 278 | 0.180 |
Why?
| | Postmenopause | 4 | 2022 | 370 | 0.180 |
Why?
| | Faculty | 1 | 2023 | 150 | 0.180 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1388 | 0.180 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 55 | 0.180 |
Why?
| | Middle Aged | 22 | 2025 | 33604 | 0.180 |
Why?
| | Malus | 1 | 2021 | 11 | 0.170 |
Why?
| | Polyphenols | 1 | 2021 | 19 | 0.170 |
Why?
| | Mentors | 1 | 2023 | 209 | 0.170 |
Why?
| | Receptors, Vasopressin | 1 | 2021 | 20 | 0.170 |
Why?
| | Thinness | 3 | 2021 | 95 | 0.170 |
Why?
| | Child Development | 2 | 2018 | 471 | 0.170 |
Why?
| | Disease Progression | 4 | 2018 | 2749 | 0.170 |
Why?
| | Hygromycin B | 1 | 2000 | 3 | 0.170 |
Why?
| | Liver X Receptors | 2 | 2019 | 29 | 0.170 |
Why?
| | Cinnamates | 1 | 2000 | 11 | 0.170 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2021 | 168 | 0.170 |
Why?
| | Hyperinsulinism | 1 | 2001 | 122 | 0.160 |
Why?
| | Kynurenine 3-Monooxygenase | 1 | 2020 | 5 | 0.160 |
Why?
| | Fruit | 1 | 2021 | 143 | 0.160 |
Why?
| | Kynurenic Acid | 1 | 2020 | 20 | 0.160 |
Why?
| | Random Allocation | 2 | 2019 | 363 | 0.160 |
Why?
| | Transcription, Genetic | 7 | 2017 | 1470 | 0.160 |
Why?
| | Starch | 1 | 2019 | 22 | 0.160 |
Why?
| | Nutritive Value | 1 | 2019 | 37 | 0.160 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2022 | 415 | 0.160 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 16 | 0.150 |
Why?
| | Cattle | 2 | 2019 | 991 | 0.150 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 26 | 0.150 |
Why?
| | Membrane Proteins | 3 | 2015 | 1145 | 0.150 |
Why?
| | Weaning | 1 | 2019 | 46 | 0.150 |
Why?
| | Metabolic Diseases | 2 | 2018 | 109 | 0.150 |
Why?
| | Retinal Ganglion Cells | 1 | 2020 | 113 | 0.150 |
Why?
| | Analysis of Variance | 4 | 2016 | 1317 | 0.150 |
Why?
| | Gene Expression Profiling | 2 | 2018 | 1746 | 0.150 |
Why?
| | Rats, Sprague-Dawley | 8 | 2015 | 2499 | 0.150 |
Why?
| | Mice, Transgenic | 7 | 2017 | 2172 | 0.140 |
Why?
| | Hyperuricemia | 1 | 2018 | 45 | 0.140 |
Why?
| | Loss of Function Mutation | 1 | 2018 | 46 | 0.140 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2020 | 199 | 0.140 |
Why?
| | Aromatase | 1 | 2018 | 32 | 0.140 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2018 | 33 | 0.140 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 151 | 0.140 |
Why?
| | Glycogen | 6 | 2010 | 52 | 0.140 |
Why?
| | Perilipin-1 | 1 | 2017 | 17 | 0.140 |
Why?
| | Rest | 1 | 2018 | 123 | 0.140 |
Why?
| | Sodium Chloride, Dietary | 1 | 2018 | 31 | 0.140 |
Why?
| | Fetal Growth Retardation | 1 | 2023 | 558 | 0.140 |
Why?
| | Models, Animal | 1 | 2019 | 395 | 0.140 |
Why?
| | Postpartum Period | 2 | 2020 | 345 | 0.140 |
Why?
| | Diglycerides | 1 | 2018 | 61 | 0.140 |
Why?
| | Cell Size | 1 | 2017 | 89 | 0.140 |
Why?
| | Urea | 1 | 2017 | 79 | 0.130 |
Why?
| | Germ Layers | 1 | 2017 | 6 | 0.130 |
Why?
| | Gastrulation | 1 | 2017 | 9 | 0.130 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 669 | 0.130 |
Why?
| | Sphingolipids | 1 | 2018 | 77 | 0.130 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2017 | 71 | 0.130 |
Why?
| | Sucrose | 2 | 2018 | 110 | 0.130 |
Why?
| | Organic Cation Transporter 2 | 1 | 2017 | 8 | 0.130 |
Why?
| | Reperfusion Injury | 1 | 2020 | 288 | 0.130 |
Why?
| | Running | 1 | 2019 | 230 | 0.130 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 62 | 0.130 |
Why?
| | Liquid-Liquid Extraction | 1 | 2016 | 14 | 0.130 |
Why?
| | Chromatography, Gas | 1 | 2016 | 33 | 0.130 |
Why?
| | Interdisciplinary Communication | 1 | 2018 | 191 | 0.130 |
Why?
| | Neural Pathways | 2 | 2011 | 303 | 0.130 |
Why?
| | Dyslipidemias | 1 | 2018 | 169 | 0.130 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 98 | 0.130 |
Why?
| | Glaucoma | 1 | 2020 | 241 | 0.130 |
Why?
| | Dogs | 1 | 2018 | 426 | 0.130 |
Why?
| | PPAR gamma | 1 | 2017 | 180 | 0.130 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 319 | 0.120 |
Why?
| | Receptors, Androgen | 1 | 2017 | 150 | 0.120 |
Why?
| | Alloxan | 1 | 2015 | 4 | 0.120 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 4 | 2019 | 56 | 0.120 |
Why?
| | Fibroblasts | 2 | 2017 | 1003 | 0.120 |
Why?
| | Corpus Striatum | 1 | 2017 | 176 | 0.120 |
Why?
| | Hypothalamus | 1 | 2016 | 153 | 0.120 |
Why?
| | Obesity, Morbid | 1 | 2000 | 271 | 0.120 |
Why?
| | Computational Biology | 1 | 2020 | 649 | 0.120 |
Why?
| | Glucokinase | 1 | 2015 | 15 | 0.120 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 2 | 2006 | 15 | 0.120 |
Why?
| | Down-Regulation | 3 | 2008 | 635 | 0.120 |
Why?
| | Malonyl Coenzyme A | 1 | 1995 | 5 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 758 | 0.120 |
Why?
| | Methylnitrosourea | 2 | 2018 | 7 | 0.120 |
Why?
| | Pediatric Obesity | 1 | 2022 | 596 | 0.120 |
Why?
| | Colorectal Neoplasms | 1 | 2023 | 777 | 0.120 |
Why?
| | Trophoblasts | 1 | 2017 | 200 | 0.110 |
Why?
| | Cholesterol, LDL | 3 | 2003 | 359 | 0.110 |
Why?
| | Caffeine | 1 | 1995 | 64 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 264 | 0.110 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 462 | 0.110 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1092 | 0.110 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 509 | 0.110 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 248 | 0.110 |
Why?
| | Infant | 5 | 2023 | 9574 | 0.110 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 2 | 2005 | 37 | 0.110 |
Why?
| | Research Report | 1 | 2014 | 86 | 0.110 |
Why?
| | Acinar Cells | 1 | 2013 | 12 | 0.100 |
Why?
| | United States | 3 | 2023 | 14938 | 0.100 |
Why?
| | Mitochondria | 3 | 2022 | 955 | 0.100 |
Why?
| | Bariatric Surgery | 1 | 2017 | 217 | 0.100 |
Why?
| | Pantothenic Acid | 1 | 2013 | 6 | 0.100 |
Why?
| | Birth Weight | 1 | 2016 | 508 | 0.100 |
Why?
| | Mitochondria, Liver | 1 | 2013 | 70 | 0.100 |
Why?
| | Circadian Rhythm | 2 | 2009 | 489 | 0.100 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1731 | 0.100 |
Why?
| | Vitamin A Deficiency | 1 | 2013 | 27 | 0.100 |
Why?
| | Vitamin A | 1 | 2013 | 57 | 0.100 |
Why?
| | Extracellular Space | 1 | 2013 | 129 | 0.100 |
Why?
| | Intestinal Mucosa | 2 | 2015 | 620 | 0.100 |
Why?
| | Integrases | 1 | 2013 | 121 | 0.100 |
Why?
| | DNA Methylation | 1 | 2017 | 629 | 0.100 |
Why?
| | Oxidative Phosphorylation | 1 | 2013 | 194 | 0.100 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 7 | 0.100 |
Why?
| | Cell Separation | 1 | 2013 | 317 | 0.090 |
Why?
| | Up-Regulation | 2 | 2013 | 851 | 0.090 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 847 | 0.090 |
Why?
| | Cytoskeleton | 1 | 2013 | 194 | 0.090 |
Why?
| | Hormones | 2 | 2010 | 140 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 873 | 0.090 |
Why?
| | Histones | 1 | 2017 | 632 | 0.090 |
Why?
| | Epithelial Cells | 2 | 2020 | 1102 | 0.090 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 2002 | 36 | 0.090 |
Why?
| | Research Design | 1 | 2018 | 1118 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 170 | 0.090 |
Why?
| | Biomarkers | 6 | 2019 | 4092 | 0.090 |
Why?
| | Interleukin-10 | 1 | 2013 | 304 | 0.090 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 2053 | 0.090 |
Why?
| | Vitamin D Deficiency | 1 | 2013 | 186 | 0.090 |
Why?
| | Multienzyme Complexes | 2 | 2001 | 66 | 0.090 |
Why?
| | Glycolysis | 1 | 2012 | 318 | 0.080 |
Why?
| | Colon | 1 | 2013 | 284 | 0.080 |
Why?
| | Pulmonary Alveoli | 1 | 2013 | 408 | 0.080 |
Why?
| | Infant, Newborn | 3 | 2018 | 6144 | 0.080 |
Why?
| | Patient Compliance | 1 | 2014 | 598 | 0.080 |
Why?
| | Colorado | 2 | 2019 | 4555 | 0.080 |
Why?
| | Lipoproteins, VLDL | 2 | 2000 | 19 | 0.080 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2012 | 368 | 0.080 |
Why?
| | Metalloproteases | 1 | 2010 | 42 | 0.080 |
Why?
| | Acetaminophen | 1 | 2012 | 258 | 0.080 |
Why?
| | Perilipin-2 | 3 | 2015 | 41 | 0.080 |
Why?
| | Alkylating Agents | 1 | 2009 | 24 | 0.080 |
Why?
| | Bone and Bones | 1 | 2012 | 317 | 0.080 |
Why?
| | Mitochondrial Proteins | 2 | 2010 | 258 | 0.080 |
Why?
| | Hypertension | 1 | 2018 | 1242 | 0.080 |
Why?
| | Species Specificity | 1 | 2011 | 581 | 0.080 |
Why?
| | Fats | 1 | 2009 | 18 | 0.080 |
Why?
| | Adolescent | 6 | 2025 | 21564 | 0.080 |
Why?
| | Cholesterol, HDL | 2 | 2000 | 195 | 0.080 |
Why?
| | Glucose Clamp Technique | 2 | 2018 | 196 | 0.080 |
Why?
| | Young Adult | 6 | 2025 | 13305 | 0.070 |
Why?
| | Health Behavior | 1 | 2014 | 773 | 0.070 |
Why?
| | Lipid Peroxidation | 1 | 2009 | 151 | 0.070 |
Why?
| | Interleukin-4 | 1 | 2009 | 214 | 0.070 |
Why?
| | Hypoglycemic Agents | 2 | 2017 | 1341 | 0.070 |
Why?
| | Self Report | 1 | 2013 | 839 | 0.070 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2013 | 352 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2339 | 0.070 |
Why?
| | Disease Susceptibility | 3 | 2016 | 349 | 0.070 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2014 | 199 | 0.070 |
Why?
| | Interleukin-2 | 1 | 2009 | 451 | 0.070 |
Why?
| | Cross-Over Studies | 2 | 2021 | 556 | 0.070 |
Why?
| | Risk Factors | 3 | 2018 | 10252 | 0.070 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2007 | 26 | 0.070 |
Why?
| | Phosphorylation | 2 | 2012 | 1760 | 0.070 |
Why?
| | Hyperplasia | 1 | 2008 | 176 | 0.070 |
Why?
| | Antigens, CD34 | 1 | 2007 | 89 | 0.070 |
Why?
| | Treatment Outcome | 3 | 2016 | 10923 | 0.070 |
Why?
| | Patient Selection | 2 | 2009 | 676 | 0.070 |
Why?
| | Metabolic Networks and Pathways | 2 | 2022 | 182 | 0.070 |
Why?
| | Body Temperature Regulation | 1 | 2008 | 100 | 0.060 |
Why?
| | Leukocyte Count | 1 | 2007 | 326 | 0.060 |
Why?
| | Cell Line | 3 | 2019 | 2876 | 0.060 |
Why?
| | Lactates | 3 | 1995 | 85 | 0.060 |
Why?
| | Exercise Test | 1 | 2009 | 622 | 0.060 |
Why?
| | Transplantation Conditioning | 1 | 2007 | 183 | 0.060 |
Why?
| | Calorimetry | 3 | 2012 | 71 | 0.060 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 62 | 0.060 |
Why?
| | Gluconeogenesis | 1 | 2006 | 78 | 0.060 |
Why?
| | Interleukin-6 | 2 | 2022 | 785 | 0.060 |
Why?
| | Reference Values | 1 | 2007 | 799 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2013 | 1992 | 0.060 |
Why?
| | Peptide YY | 1 | 2025 | 17 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2022 | 1518 | 0.060 |
Why?
| | Retrospective Studies | 3 | 2018 | 15909 | 0.060 |
Why?
| | Glucose Transporter Type 4 | 2 | 2002 | 39 | 0.060 |
Why?
| | Sterol Regulatory Element Binding Protein 2 | 1 | 2005 | 7 | 0.060 |
Why?
| | Models, Biological | 2 | 2018 | 1806 | 0.060 |
Why?
| | Lipolysis | 1 | 2005 | 46 | 0.060 |
Why?
| | Case-Control Studies | 3 | 2019 | 3523 | 0.060 |
Why?
| | Proteomics | 2 | 2022 | 1110 | 0.060 |
Why?
| | Proteins | 2 | 2013 | 1006 | 0.060 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2006 | 208 | 0.050 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2025 | 140 | 0.050 |
Why?
| | Macrophages | 1 | 2012 | 1543 | 0.050 |
Why?
| | Antigens, CD | 1 | 2007 | 536 | 0.050 |
Why?
| | Kinetics | 2 | 2012 | 1645 | 0.050 |
Why?
| | Pilot Projects | 2 | 2022 | 1765 | 0.050 |
Why?
| | Organ Specificity | 1 | 2005 | 310 | 0.050 |
Why?
| | Myogenic Regulatory Factors | 2 | 2001 | 55 | 0.050 |
Why?
| | MEF2 Transcription Factors | 2 | 2001 | 59 | 0.050 |
Why?
| | Cholesterol, VLDL | 1 | 2003 | 5 | 0.050 |
Why?
| | RNA, Small Interfering | 1 | 2006 | 626 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 385 | 0.050 |
Why?
| | Endoplasmic Reticulum | 2 | 2018 | 265 | 0.050 |
Why?
| | Food Deprivation | 1 | 2003 | 27 | 0.050 |
Why?
| | Protein Kinases | 2 | 2002 | 308 | 0.050 |
Why?
| | Occult Blood | 1 | 2023 | 34 | 0.050 |
Why?
| | Hexokinase | 1 | 2022 | 18 | 0.050 |
Why?
| | Absorptiometry, Photon | 1 | 2004 | 264 | 0.050 |
Why?
| | Aged | 5 | 2018 | 24024 | 0.050 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 21 | 0.050 |
Why?
| | Ethers | 1 | 2022 | 19 | 0.050 |
Why?
| | Lactic Acid | 4 | 2002 | 303 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2022 | 112 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 2030 | 0.050 |
Why?
| | Adipokines | 1 | 2022 | 47 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2022 | 76 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 86 | 0.050 |
Why?
| | Leucine | 1 | 2022 | 116 | 0.050 |
Why?
| | Rodentia | 1 | 2022 | 59 | 0.050 |
Why?
| | Subcutaneous Fat | 1 | 2022 | 81 | 0.050 |
Why?
| | Diphtheria Toxin | 1 | 2022 | 65 | 0.050 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2013 | 41 | 0.050 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2022 | 129 | 0.050 |
Why?
| | Docosahexaenoic Acids | 1 | 2022 | 86 | 0.050 |
Why?
| | Dinoprostone | 1 | 2022 | 191 | 0.050 |
Why?
| | Mice, Obese | 1 | 2021 | 67 | 0.050 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2001 | 12 | 0.050 |
Why?
| | Interleukin-13 | 1 | 2022 | 148 | 0.040 |
Why?
| | Aromatase Inhibitors | 1 | 2021 | 58 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2022 | 271 | 0.040 |
Why?
| | Diabetes Complications | 1 | 2003 | 223 | 0.040 |
Why?
| | Neutrophils | 1 | 2007 | 1274 | 0.040 |
Why?
| | Waist Circumference | 1 | 2021 | 132 | 0.040 |
Why?
| | Tumor Burden | 1 | 2022 | 309 | 0.040 |
Why?
| | Phospholipids | 1 | 2022 | 219 | 0.040 |
Why?
| | Hep G2 Cells | 1 | 2021 | 67 | 0.040 |
Why?
| | Drinking | 1 | 2021 | 42 | 0.040 |
Why?
| | Intestines | 2 | 2015 | 356 | 0.040 |
Why?
| | Hemoglobins | 1 | 2023 | 357 | 0.040 |
Why?
| | Blotting, Southern | 1 | 2000 | 75 | 0.040 |
Why?
| | Colonoscopy | 1 | 2023 | 243 | 0.040 |
Why?
| | Calmodulin | 1 | 2000 | 71 | 0.040 |
Why?
| | Hindlimb | 3 | 1995 | 133 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2022 | 728 | 0.040 |
Why?
| | Calcineurin | 1 | 2000 | 107 | 0.040 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2020 | 104 | 0.040 |
Why?
| | Lipoproteins, HDL | 1 | 2000 | 77 | 0.040 |
Why?
| | Genes, Reporter | 1 | 2000 | 274 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2018 | 7677 | 0.040 |
Why?
| | Lipoproteins, LDL | 1 | 2000 | 113 | 0.040 |
Why?
| | Medicago sativa | 1 | 2019 | 3 | 0.040 |
Why?
| | Rumen | 1 | 2019 | 7 | 0.040 |
Why?
| | Dairying | 1 | 2019 | 8 | 0.040 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2019 | 17 | 0.040 |
Why?
| | Benzylamines | 1 | 2019 | 43 | 0.040 |
Why?
| | New Zealand | 1 | 2019 | 54 | 0.040 |
Why?
| | Protein Kinase C | 1 | 2000 | 252 | 0.040 |
Why?
| | Benzoates | 1 | 2019 | 45 | 0.040 |
Why?
| | Postprandial Period | 1 | 2019 | 110 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2019 | 208 | 0.040 |
Why?
| | Child | 2 | 2022 | 21921 | 0.040 |
Why?
| | Prospective Studies | 2 | 2023 | 7554 | 0.040 |
Why?
| | Mathematical Concepts | 1 | 2018 | 33 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5520 | 0.040 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2019 | 120 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2019 | 135 | 0.040 |
Why?
| | Japan | 1 | 2018 | 127 | 0.040 |
Why?
| | Early Detection of Cancer | 1 | 2023 | 426 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2023 | 1941 | 0.040 |
Why?
| | Huntingtin Protein | 1 | 2017 | 13 | 0.040 |
Why?
| | Transfection | 1 | 2000 | 941 | 0.030 |
Why?
| | Sarcolemma | 1 | 2018 | 42 | 0.030 |
Why?
| | Stromal Cells | 1 | 2018 | 112 | 0.030 |
Why?
| | Nuclear Transfer Techniques | 1 | 2017 | 3 | 0.030 |
Why?
| | Trinucleotide Repeat Expansion | 1 | 2017 | 44 | 0.030 |
Why?
| | Comparative Genomic Hybridization | 1 | 2017 | 29 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 321 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2000 | 663 | 0.030 |
Why?
| | Estrogen Replacement Therapy | 1 | 1998 | 140 | 0.030 |
Why?
| | Cytokines | 2 | 2018 | 2080 | 0.030 |
Why?
| | Neoplasms | 1 | 2012 | 2681 | 0.030 |
Why?
| | Muscle Contraction | 1 | 2000 | 431 | 0.030 |
Why?
| | Blastocyst | 1 | 2017 | 47 | 0.030 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2017 | 27 | 0.030 |
Why?
| | Breast | 1 | 2018 | 158 | 0.030 |
Why?
| | Phenylthiohydantoin | 1 | 2017 | 41 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1244 | 0.030 |
Why?
| | Cyclic AMP | 2 | 1995 | 219 | 0.030 |
Why?
| | Biological Specimen Banks | 1 | 2018 | 98 | 0.030 |
Why?
| | Cytosol | 1 | 2018 | 227 | 0.030 |
Why?
| | Brain | 2 | 2021 | 2792 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2000 | 613 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 165 | 0.030 |
Why?
| | Isoenzymes | 2 | 2012 | 303 | 0.030 |
Why?
| | Water Deprivation | 1 | 2016 | 5 | 0.030 |
Why?
| | Meat | 1 | 2018 | 93 | 0.030 |
Why?
| | Erythrocytes | 1 | 2022 | 701 | 0.030 |
Why?
| | Ectoderm | 1 | 2017 | 53 | 0.030 |
Why?
| | Animals, Genetically Modified | 1 | 2017 | 242 | 0.030 |
Why?
| | Methylation | 1 | 2017 | 227 | 0.030 |
Why?
| | Epinephrine | 2 | 1994 | 145 | 0.030 |
Why?
| | Progesterone | 1 | 1998 | 258 | 0.030 |
Why?
| | Fertilization in Vitro | 1 | 2017 | 84 | 0.030 |
Why?
| | Nutrition Surveys | 1 | 2018 | 270 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2017 | 193 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2020 | 1192 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 366 | 0.030 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 157 | 0.030 |
Why?
| | Steroids | 1 | 2017 | 163 | 0.030 |
Why?
| | Nitriles | 1 | 2017 | 176 | 0.030 |
Why?
| | Benzamides | 1 | 2017 | 213 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 599 | 0.030 |
Why?
| | Teratoma | 1 | 2017 | 118 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 852 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 2017 | 178 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 448 | 0.030 |
Why?
| | Phosphocreatine | 1 | 1995 | 45 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2022 | 1316 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2019 | 1949 | 0.030 |
Why?
| | Adenosine Monophosphate | 1 | 1995 | 67 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 4181 | 0.030 |
Why?
| | Fructosediphosphates | 1 | 1994 | 1 | 0.030 |
Why?
| | Calcium | 1 | 2000 | 1180 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 24 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 849 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1072 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2014 | 345 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2017 | 734 | 0.030 |
Why?
| | Perfusion | 1 | 1995 | 225 | 0.030 |
Why?
| | Lipids | 1 | 1998 | 675 | 0.030 |
Why?
| | Hot Temperature | 1 | 2016 | 393 | 0.030 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.030 |
Why?
| | Testosterone | 1 | 2017 | 402 | 0.030 |
Why?
| | Cell Respiration | 1 | 2013 | 103 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3307 | 0.030 |
Why?
| | Laser Capture Microdissection | 1 | 2013 | 32 | 0.030 |
Why?
| | Betaine | 1 | 2013 | 64 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 86 | 0.020 |
Why?
| | Muscles | 1 | 1994 | 332 | 0.020 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2015 | 553 | 0.020 |
Why?
| | Fatty Acids, Nonesterified | 3 | 2002 | 158 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 639 | 0.020 |
Why?
| | Sex Factors | 1 | 2018 | 2044 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2012 | 149 | 0.020 |
Why?
| | Intestine, Small | 1 | 2013 | 156 | 0.020 |
Why?
| | Collagen Type I | 1 | 2012 | 139 | 0.020 |
Why?
| | Blood Pressure | 1 | 2018 | 1739 | 0.020 |
Why?
| | Prevalence | 1 | 2018 | 2727 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 761 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2844 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 309 | 0.020 |
Why?
| | Metabolism | 1 | 2010 | 43 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2013 | 513 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2000 | 1818 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 3392 | 0.020 |
Why?
| | Hypoglycemia | 1 | 1994 | 460 | 0.020 |
Why?
| | Glycerol | 1 | 2009 | 91 | 0.020 |
Why?
| | Liver Glycogen | 2 | 2002 | 16 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 3433 | 0.020 |
Why?
| | Proteome | 1 | 2013 | 469 | 0.020 |
Why?
| | Phenotype | 2 | 2008 | 3139 | 0.020 |
Why?
| | Trans-Activators | 1 | 2010 | 385 | 0.020 |
Why?
| | Birds | 1 | 2008 | 95 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2010 | 624 | 0.020 |
Why?
| | Body Temperature | 1 | 2008 | 224 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 976 | 0.020 |
Why?
| | Carbon Radioisotopes | 1 | 2006 | 31 | 0.020 |
Why?
| | Palmitates | 1 | 2006 | 18 | 0.020 |
Why?
| | Orphan Nuclear Receptors | 1 | 2006 | 14 | 0.020 |
Why?
| | Breeding | 1 | 2006 | 65 | 0.020 |
Why?
| | Glucose-6-Phosphatase | 1 | 2006 | 33 | 0.020 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2006 | 30 | 0.020 |
Why?
| | PPAR alpha | 1 | 2006 | 57 | 0.020 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 31 | 0.020 |
Why?
| | Intestinal Absorption | 1 | 2006 | 92 | 0.020 |
Why?
| | Adenoviridae | 1 | 2006 | 200 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2006 | 241 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 2006 | 202 | 0.010 |
Why?
| | Introns | 1 | 2005 | 254 | 0.010 |
Why?
| | Enzymes | 1 | 2003 | 64 | 0.010 |
Why?
| | Uncoupling Protein 3 | 1 | 2002 | 8 | 0.010 |
Why?
| | Oxazoles | 1 | 2002 | 36 | 0.010 |
Why?
| | Ketones | 1 | 2002 | 48 | 0.010 |
Why?
| | Thiazoles | 1 | 2002 | 126 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2850 | 0.010 |
Why?
| | Ion Channels | 1 | 2002 | 127 | 0.010 |
Why?
| | Ribonucleotides | 1 | 2001 | 26 | 0.010 |
Why?
| | Tyrosine | 1 | 2002 | 227 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2001 | 810 | 0.010 |
Why?
| | Aging | 1 | 2010 | 1855 | 0.010 |
Why?
| | RNA | 1 | 2003 | 925 | 0.010 |
Why?
| | Administration, Oral | 1 | 1998 | 788 | 0.010 |
Why?
| | Adrenal Medulla | 1 | 1994 | 9 | 0.010 |
Why?
| | Molecular Weight | 1 | 1995 | 327 | 0.010 |
Why?
| | Phosphofructokinase-1 | 1 | 1994 | 6 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 336 | 0.010 |
Why?
| | Cyclic GMP | 1 | 1994 | 91 | 0.010 |
Why?
| | Age Factors | 1 | 2000 | 3256 | 0.010 |
Why?
| | Blotting, Western | 1 | 1995 | 1230 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 1994 | 496 | 0.010 |
Why?
|
|
MacLean's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|